FNY Partners Fund’s Exact Sciences EXAS Stock Holding History

FNY Partners Fund’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-3,000	Closed	-$70K	–	742
2017 Q1	$70K	Buy	+3,000	New	+$59.4K	0.01%	615

Other funds holding EXAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

FNY Partners Fund's EXAS Position: Q2 2017 in Review

FNY Partners Fund sold out of Exact Sciences (EXAS) in Q2 2017, closing a stake of 3,000 shares — an estimated $70K sold.

FNY Partners Fund first reported a position in EXAS in Q1 2017 and held it in 1 quarter. The position peaked at $70K in Q1 2017. 266 funds tracked by Wall St. Rank hold EXAS as of Q2 2017.

FNY Partners Fund reported no remaining Exact Sciences position as of Q2 2017 after selling out during the quarter.
FNY Partners Fund sold 3,000 Exact Sciences shares in Q2 2017, an estimated $70K.
FNY Partners Fund first reported a position in Exact Sciences in Q1 2017 and held it in 1 quarter.
FNY Partners Fund's Exact Sciences position peaked at $70K in Q1 2017.
266 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2017.

Based on FNY Partners Fund's 13F filing for Q2 2017, filed 10 Aug 2017.